0001415889-24-004403.txt : 20240220 0001415889-24-004403.hdr.sgml : 20240220 20240220170245 ACCESSION NUMBER: 0001415889-24-004403 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240215 FILED AS OF DATE: 20240220 DATE AS OF CHANGE: 20240220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jansen Valerie Malyvanh CENTRAL INDEX KEY: 0001889716 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40523 FILM NUMBER: 24654618 MAIL ADDRESS: STREET 1: C/O ELEVATION ONCOLOGY, INC. STREET 2: 888 SEVENTH AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Elevation Oncology, Inc. CENTRAL INDEX KEY: 0001783032 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 841771427 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 FEDERAL STREET STREET 2: SUITE 1900 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 7163711125 MAIL ADDRESS: STREET 1: 101 FEDERAL STREET STREET 2: SUITE 1900 CITY: BOSTON STATE: MA ZIP: 02110 FORMER COMPANY: FORMER CONFORMED NAME: 14ner Oncology, Inc. DATE OF NAME CHANGE: 20190719 4 1 form4-02202024_100233.xml X0508 4 2024-02-15 0001783032 Elevation Oncology, Inc. ELEV 0001889716 Jansen Valerie Malyvanh C/O ELEVATION ONCOLOGY, INC. 101 FEDERAL STREET, SUITE 1900 BOSTON MA 02110 false true false false CHIEF MEDICAL OFFICER 0 Stock Option (Right to Buy) 2.77 2024-02-15 4 A 0 225000 0 A 2034-02-14 Common Stock 225000 225000 D Restricted Stock Unit 2024-02-15 4 A 0 70000 0 A Common Stock 70000 70000 D The stock option vests as to 25% of the total shares on February 15, 2025, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs vest on February 15, 2025, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. The RSUs do not expire; they either vest or are canceled prior to the vesting date. /s/ Robert Yang, Attorney-in-Fact 2024-02-20